2014
DOI: 10.1517/17425247.2015.955847
|View full text |Cite
|
Sign up to set email alerts
|

Advances in an active and passive targeting to tumor and adipose tissues

Abstract: Unlike tumor tissues, only a few reports have appeared on how liposomal carriers accumulate in adipose tissues after systemic injection. This finding, as well as active targeting to the adipose vasculature, promises to extend the capacity of DDS to adipose tissue. Since the site of action of nucleic acids is the cytosol, the intracellular trafficking of carriers and their cargoes as well as cellular uptake must be taken into consideration.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
39
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 48 publications
(39 citation statements)
references
References 104 publications
0
39
0
Order By: Relevance
“…[13][14][15] The potential of such drug delivery vehicles in biomedicine is illustrated by the fact that they not only prolong the circulation time of their payloads and protect them from premature degradation, but can also be actively or passively targeted to desired tissues and organs. 16 This results in an increase of the bioavailability of a drug and a reduction of side effects. In this context, the shape, size, and rigidity of nanoparticulate therapeutic agents play a key role in determining their uptake efficiency, circulation time, and distribution in the body.…”
Section: Introductionmentioning
confidence: 99%
“…[13][14][15] The potential of such drug delivery vehicles in biomedicine is illustrated by the fact that they not only prolong the circulation time of their payloads and protect them from premature degradation, but can also be actively or passively targeted to desired tissues and organs. 16 This results in an increase of the bioavailability of a drug and a reduction of side effects. In this context, the shape, size, and rigidity of nanoparticulate therapeutic agents play a key role in determining their uptake efficiency, circulation time, and distribution in the body.…”
Section: Introductionmentioning
confidence: 99%
“…However, margination is not limited to WBCs and has been observed for other particles as well (2). This has sparked a lot of interest because of its potential applications in relation to cancer therapy (3)(4)(5)(6)(7). Tumor sites are generally characterized by 1) leaky vasculature, which allows drugcarrying particles to diffuse into them, and 2) a lack of lymphatics, which allows these particles to remain inside the tumor.…”
Section: Introductionmentioning
confidence: 99%
“…As soon as the conjugate is internalized into the tumour cell, the DDS must quickly release the cytotoxic drug to be effective. Similarly, the radiopharmaceutical linked to the tumour cell must be given adequate time for the DDS to emit the radiation dose and image the tumour cells [1][2][3].…”
Section: Introductionmentioning
confidence: 99%
“…The accumulation of macromolecules, including plasma proteins, does not require a specific receptor. Therefore, the mechanism of EPR probably acts as a passive transport system within the cells [1][2][3].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation